Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 1, 2001 - Issue 1
Submit an article Journal homepage
41
Views
21
CrossRef citations to date
0
Altmetric
Review

Islet cell transplantation for the treatment of diabetes mellitus

William F Kendall Box 3065, Duke University Medical Center, Durham, NC 27710, USA. [email protected]
,
Bradley H Collins Box 3065, Duke University Medical Center, Durham, NC 27710, USA. [email protected]
&
Emmanuel C Opara Box 3065, Duke University Medical Center, Durham, NC 27710, USA. [email protected]
Pages 109-119 | Published online: 23 Feb 2005

Bibliography

  • CHUDLEY AE: Genetic landmarks through philately -a brief history of diabetes mellitus. Clin. Genet. (1999) 55 (4) :231–233.
  • ONAT T: The history of endocrinology in philately. J Pediatr. Endocrinol. Metabol. (1997) 10:371–377.
  • SAFRAN MA, VINICOR F: The war against diabetes. How will we know if we are winning? Diabetes Care (1999) 3:508–516.
  • SEIDELL JC: Obesity, insulin resistance and diabetes - a worldwide epidemic. Br. J. Nutr. (2000) 83 (Suppl. 1) :5–8.
  • KING H, AUBERT RE, HERMAN WH: Global burden of diabetes, 1995–2025: prevalence, numerical estimates and projections. Diabetes Care (1998) 21 (9):1414–1431. This article presents a global overview on the impact of diabetes.
  • HARRIS MI, FLEGAL KM, COWIE CC: Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults. Diabetes Care (1998) 21:518–524.
  • HARRIS MI: Diabetes in America:epidemiology andscope of the problem. Diabetes Care (1998) 21 (Supp1.3) :C11–14.
  • AMERICA DIABETES ASSOCIATION: Economicconsequences of diabetes in the US in 1997. Diabetes Care (1998) 21 (2) :296–309
  • JONSSON B: The economic impact of diabetes. DiabetesCare (1998) 21 (Suppl. 3):C7–C10.
  • OPARA EC: The therapeutic potential of islet celltransplant in the treatment of diabetes. Exp. Opin. Invest. Drugs. (1998) 7 (5) :785–795.
  • GAVIN JR 3rd: New classification and diagnostic criteriafor diabetes mellitus. Clinical Cornerstone. (1998) 1 (3):1–12.
  • BACH JF: Insulin-dependent diabetes mellitus is an autoimmune disease. Endocr. Rev. (1994) 15:516–542.
  • RABINOVITCH A, SUAREZ-PINZON WL: Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem. Pharmacol. (1998) 55(8):1139–1149.
  • MAURICIO D, MANDRUP-PAULSEN T: Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes (1998) 47(10):1537–1543.
  • KAHN R: Type 2 diabetes in children and adolescents. Pediatrics (2000) 105 (3) :671–680.
  • DEFRONZO RA: The triumvirate: B-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes (1988) 37:667–687.
  • OPARA EC, PETRO A, TEVRIZIAN A, FEINGLOS MN, SURWIT RS: L-Glutamine supplementation of a high-fat diet reduces body weight and attenuates hypergly-cemia and hyperinsulinemia inC57BL/6J mice. J. Nutr. (1996) 126:273–279.
  • STORLIEN LH, BAUR LA, KRIKETOS AD et al.: Dietary fats and insulin action. Diabetologia (1996) 39:621–631.
  • HARRIS MI: Descriptive epidemiology. In: Diabetes in America (2nd Edition). NIDDK, National Institutes of Health, Bethesda, MD, USA (1995).
  • AKBARI CM, LO GERFO FW: Diabetes and peripheral vascular disease. J Vasc. Surg. (1999) 30 (2):373–384.
  • WILLIAMS SB, CUSCO JA, RODDY M, JOHNSTONE MY, CREAGER MA: Impaired nitric oxide-mediated vasodi-lation in patients with non-insulin -dependent diabetes mellitus. j. Am. Coll. Cardiol. (1996) 27:567–574.
  • JOHNSTONE MT, CREAGER SJ, SCALES KM, CUSCO JA, LEEBK, CREAGER MA: Impaired endothelium dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. (1993) 88:2510–2516.
  • KOYA D, KING GL: Protein Kinase C activation and thedevelopment of diabetic complications. Diabetes. (1998) 47 (6):859–866.
  • SCHMIDT AM, YAN SD, WAUTIER JL, STERN D: Activationof receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res. (1999) 84(5):489–497.
  • OPARA EC, ABDEL-RAHMAN E, SOLIMAN S et al.:Depletion of total antioxidant capacity in Type 2 diabetes. Metabolism (1999) 4 8 (10:1414–1417.
  • THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl. J. Med. (1993) 329 (14):977–986.
  • ••This study unequivocally showed that strict glycaemiccontrol had significant delay effects on the onset and progression of diabetic complications.
  • KELLY WD, LILLEHEI RC, MERKEL FK, IDEZUKI Y, GOETZ FC: Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephro-pathy. Surgery (1967) 61:827–837.
  • BOREL JF, FEURER C, GUBLER HU, STAHELIN H: Biological effects of cyclosporin A: anew antilympho-cytic agent. Agents Actions (1976) 6(4):468–475.
  • SOLLINGER HW, ODORICO JS, KNECHTLE SJ, D'ALES-SANDRO AM, KALAYOGLU M, PIRSCH JD: Experience with 500 simultaneous pancreas-kidney transplants. Ann. Surg. (1998) 228 (3):284–296.
  • REICHARD P, NILSSON BY, ROSENQVIST U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl..) Med. (1993) 329 (5):304–309.
  • •This study clearly showed that strict glycaemic control can prevent some of of the complications of diabetes.
  • SOLDERS G, TYDEN G, PERSSON A, GROTH CG: Improvement of nerve conduction in diabetic neuropathy: a follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes ( 1992) 41:946–951.
  • •This study shows that strict hyperglycaemic control can reverse some of the complications of diabetes.
  • BILOUS RW, MAUER SM, SUTHERLAND DER, NAJARIAN JS, GOETZ FC, STEFFES MW: The effect of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl. J. Med (1989) 321 (2):80–85.
  • •This study clearly showed that strict glycaemic control can prevent some of the complications of diabetes.
  • HATHAWAY DK, ABELL T, CARDOSO S, HARTWIG MS, GEBELY SE, GABER AO: Improvement in autonomic and gastric function following pancreas-kidney versus kidney alone transplantation and the correla-tion with quality of life. Transplantation (1994) 57 (6):816–822.
  • CALDARA R, LA ROCCA E, MAFFI P, SECCHI A: Effect of pancreas transplantation on late complications of diabetes and metabolic effects of pancreas and islet transplantation. J. Pediatr. Endocrinol. Metab. (1999) 12:777–787.
  • ORLOFF MJ, GREENLEAF GE, URBAN P, GIRARD B: Lifelong reversal of the metabolic abnormalities of advanced diabetes in rats by whole-pancreas transplantation. Transplantation (1986) 41 (5):556–564.
  • IDO Y, VINDIGNI A, CHANG K et al.: Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science (1997) 277 (5325):563–566.
  • ••This study shows for the first time that c-peptide which wasthought not to have any significant biologic function may play a role in prevention of diabetic complications.
  • BRUNICARDI FC, MULLEN Y: Issues in clinical islet transplantation. Pancreas (1994) 9(3):281–290.
  • BERTUZZI F, SECCHI A, ALDRIGHETTI L, NANO R, POZZA G, DI CARLO V: Islet transplantation in diabetic patients. J. Pediatr. Endocrinol. Metabol. (1999) 12:771–775.
  • FARNEY AC, NAJARIAN JS, NAKLEH RE et al.: Autotr ans-plantation of dispersed pancreatic islet tissue combined with total or near total pancreatectomy for treatment of chronic pancreatitis. Surgery (1991) 210:427–439.
  • ANGELICO MC, ALEJANDRO R, NERY J et al.: Transplanta-tion of islets of langerhans in patients with insulin requiring diabetes mellitus undergoing orthotopic liver transplantation. j Mol. Med. (1999) 77:144–147.
  • OBERHOLZER J, TRIPONEZ F, MAGE R et al.:Human islet transplantation: Lessons from 13 autologous and 13 allogeneic transplantations. Transplantation (2000) 69(0:1115–1123.
  • RILO HL, CARROLL PB, TZAKIS A et al.:Insulin independ-ence for 58 months following pancreatic islet cell transplantation in a patient undergoing upper abdominal ex enteration. Transplant Proc. (1995) 27(0:3164–3165.
  • WARNOCK GL, KNETEMAN NM, RYAN EA, RABINOVITCH A, RAJOTTE RV: long-term follow-up after transplanta-tion of insulin producing pancreatic islets into patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetalogia. (1992) 35:89–95.
  • ALEJANDRO R, LEHMANN R, RICORDI C et al.:Long-term function (6 years) of islet allografts in Type 1 diabetes. Diabetes (1997) 46 (12) :1983–1989.
  • •First study showing long-term survival of transplanted pancreatic islets.
  • FEDERLIN KF, BRETZEL RG: Achievements in 20 years of islet transplantation research. Transplant Proc. (1986) 18(0:1809–1813.
  • SHAPIRO AMJ, LAKEY JRT, RYAN EA et al.: Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppres-sive regimen. N Engl. J. Med (2000) 343 (4):230–238.
  • ••Study showing reproducibility and efficacy of pancreaticislet transplantation. Also indicative of ongoing change in current approach to immunosuppression.
  • KENYON NS, RANUNCOLI A, MASETTI M, CHATZIPETROU M, RICORDI C: Islet transplantation: present and future perspectives. Diabetes Metab. Rev. (1998) 14(4):303–313.
  • STRATTA RJ: Review of immunosuppressive usage in pancreas transplantation. Clin. Transplant (1999) 13(1 Pt 0:1–12.
  • BUTLER D: FDA warns on primate xenotransplants. Nature (1999) 398:549.
  • GALILI U: Evolution of al, 3 Galactosyltransferase and of the a-gal epitope. In: Subcellular Biochemistry, (Volume 32): a-gal and Anti-Gal. Kluwer Academic/Plenum Publishers, New York, USA (1999).
  • NOWAK R: Pig transplants offer hope in diabetes. Science (1994) 266:1323.
  • DOBSON R: Cloning of pigs bring xenotransplants closer. Br. Med. J. (2000) 320(7238):826.
  • LOGAN JS, SHARMA A: Potential use of genetically modified pigs as organ donors for transplantation into humans. Clin. Exp. Phramacol. Physiol. (1999) 26:1020–1025.
  • COZZI E, WHITE DJ: The generation of transgenic pigs as potential organ donors for humans. Nature Med. (1995) 1 (9):964–966.
  • HENEINE W, TIBELL A, SWITZER WM et al: No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet (1998) 352:695–699.
  • PARADIS K, LANGFORD G, LONG Z et al: Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science (1999) 285(5430:1236–1241.
  • ••In 160 patients, with longest follow-up approximately 12years, there was no evidence of retroviral transmission.
  • CHART RS, COLLINS BH, MAGEE JC et al.: Brief report: treatment of hepatic failure with ex-vivo pig-liver perfusion followed by liver transplantation. N Engl. J Med. (1994) 331 (4):234–237.
  • WEIR GC, BONNER-WEIR S: Scientific and political impediments to successful islet transplantation. Diabetes (1997) 46(8):1247–1256.
  • MCKENZIE IFC, KOULMANDA M, MANDEL T, SANDRIN MS: Expression of Gal a(1,3) Gal by porcine islet cells and its relevance to xenotransplantation. Xenotrans-plantation (1995) 2:139–142
  • •Isolated adult pig islets may not have Gal a (1,3) Gal epitope.
  • TACKE SJ, KURTH R, DENNER J: Porcine endogenous retroviruses inhibit human immune cell function: risk for x en o tr an splan tation? Virology (2000) 268:87–93.
  • CHING CD, HARLAND RC, COLLINS BH, KENDALL W, HOBBS H, OPARA EC: Areliable method for isolation of viable porcine islets. Arch. Surg. (In Press).
  • ••Highly reproducible procedure to isolate intact rather thanfragmented porcine islets.
  • CHARLES K, HARLAND RC, CHING D, OPARA EC: Storage and microencapsulation of islets for transplantation. Cell Transplant. (2000) 9:33–38.
  • •Shows procedure with tremendous impact for routine use of islet cell transplants.
  • CRETIN N, BUHLER L, FOURNIER B et al.: Human islet allotransplantation: world experience and current status. Dig. Surg. (1998) 15:656–662.
  • KOJIMA Y, NAKAGAWARA G, IMABORI T, TAKEYAMA S, NOTE M, MIYAZAKI I: Experimental studies on cryopre-servation combined with the cultural process of isolated rat pancreatic islets. Jpn. J. Surg. (1982) 12:463–467
  • SANDLER S, ANDERSSON A. The significance of culturefor successful cryopreservation of isolated pancreatic islets of langerhans. Cryobiology (1984) 21:503–510.
  • TAYLOR MJ, BANK HL. Function of lymphocytes and macrophages after cryopreservation by procedures for pancreatic islets: potential for reducing tissue immunogenicity. Cryobiology (1988) 25:1–17.
  • TAYLOR MJ, BANK HL, BENTON MJ. Selective destruc-tion of leukocytes by freezing as a potential means of modulating tissue immunogenicity: membrane integrity of lymphocytes and macrophages. Cryobi-ology (1987) 24:91–102.
  • FOREMAN J, MORIYA H, TAYLOR MJ. Effect of cooling and its interaction with pre-freeze and post-thaw tissue culture on the in vitro and in vivo function of cryopreserved pancreatic islets. Transpl. Int. (1993) 6:191–200.
  • BAILEY CJ, DAVIES EL, DOCHERTY K: Prospects forinsulin delivery by ex-vivo somatic cell gene therapy. Mol Med. (1999) 77:244–249.
  • TIEDGE M, ELSNER M, MCCLENAGHAN NH et al.: Engineering of a glucose-responsive surrogate cell for insulin replacement therapy of experimental insulin-dependent diabetes. Hum. Gene Ther. (2000) 11:403–414.
  • BROWNLEE M: Generation of non-immune islet cellsusing genetic engineering. J. Mol. Med. (1999) 77:230–234.
  • SORIA B, ROCHE E, BERNA' G, LEO'N-QUINTO T, REIG JA,MARTIN F: Insulin -secreting cells derived from embryonic stem cells normalize glycemia in streptozocin-induced diabetic mice. Diabetes (2000) 49(2):157–162.
  • •Suggests newer options for source of islets.
  • BONNER-WEIR S, TANEJA M, WEIR GC et al.: In-vitro cultivation of human islets from expanded ductal tissue. Proc. Natl. Acad. ScL USA (2000) 97(14):7999–8004.
  • •Suggests newer options for source of islets.
  • SLAVIN S, PRIGHOZINA T, GUREVITCH 0 et al.: New approaches for control of anti-self reactivity in Type 1 diabetes mellitus and transplantation of pancreatic islets. J. Mol. Med. (1999) 77:223–225.
  • RAMIYA VK, MARAIST M, ARFORS KE, SCHATZ DA, PECK AB, CORNELIUS JG: Reversal of insulin-dependent diabetes using islets generated in vitro from pancre-atic stem cells. Nature Med. (2000) 6(3):278–282.
  • BACH FH, ROBSON SC, WRIGHTON CJ, STUHLMEIER K, FERRAN C, WINKLER H: Genetic engineering of endothelial cells to ameliorate xenograft rejection. Clin. Transplant. (1996) 1O(1):124–127.
  • EFRAT S: Genetically engineered pancreatic 13-celllines for cell therapy of diabetes. Ann. NY Acad. ScL (1999) 875:286–293.
  • MCCLENAGHAN NH, FLATT PR: Engineering cultured insulin-secreting pancreatic 13-cell lines. j Mol. Med. (1999) 77:235–243.
  • WEKERLE T, KURTZ J, HIROSHI I et al. Allogeneic bonemarrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nature Med. (2000) 6 (4):464–469.
  • LARSEN CP, ELWOOD ET, ALEXANDER DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD 28 pathways. Nature (1996) 381 (6580:434–438.
  • KIRK AD, BURKLY LC, BATTY DS et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Med. (1999) 5(6):686–93.
  • Pancreatic Islet Transplantation: Volume III, Iminunoisola-tion of Pancreatic Islets. Lanza RP, Chick WL (Eds.), RG Landes Co., Georgetown, USA (1994).
  • RICORDI C: Recent advances in alginate-based microcapsules. In: Pancreatic Islet Cell Transplantation RG Landes, Georgetown, USA (1992) 191:206.
  • CHANG TMS: Semipermeable microcapsules. Science (1964) 146:524–525.
  • LIM F, SUN AM: Microencapsulated islets as a bioartifi-cial endocrine pancreas. Science (1980) 210:908–910.
  • •First description of microencapsulation as a procedure for immunoisolation of islets.
  • Pancreatic Islet Transplantation: Volume III, Immunoisola-tion of Pancreatic Islets. Lanza RP, Chick WL (Eds.), RG Landes Co., Georgetown, USA (1994) 81:94.
  • ESPEVIK T, OTTERLEI M, SKJAK-BRAEK G, RYAN L,WRIGHT SD, SUNDAN A. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur.J. Immunol. (1993) 23:255–261.
  • SOON-SHIONG P, FELDMAN E, NELSON R et al. Long-term reversal of diabetes by injection of immunoprotected islands. Proc. Natl. Acad. Sci. USA (1993) 90(12):5843–5847.
  • KULSENG B, THU B, ESPEVIK T, SKJAK-BRAEK G.Alginate polylysine microcapsules as immune barrier: permeability of cytokines and immunoglobulins over the capsule membrane. Cell Transplantation (1997) 6 (4):387–394.
  • CLAYTON HA, JAMES RFL, LONDON NJM: Islet microen-capsulation: a review. Acta Diabetol. (1993) 30 (0181–189.
  • CAPPAI A, PETRUZZO P, RUIU G et al.:Evaluation of new small barium alginate microcapsules. Int. J. Artif Organs. (1995) 18(2):96–102.
  • GARFINKEL MR, HARLAND RC, OPARA EC: Optimization of the microencapsulated islet for transplantation. J. Surg. Res. (1998) 76:7–10.
  • •Shows that chelation of inner core increases efficacy of microencapsulation.
  • SMIDSROD 0, SKJAK-BRAEK G: Alginate as immobiliza-tion matrix for cells. Trends Biotechnol. (1990) 8(3):71–78.
  • DARRABIE MD, FREEMAN BK, KENDALL JR WF, HOBBS HA, OPARA EC: Durability of sodium sulfate-treated polylysine-alginate microcapsules. j Biomed. Mater. Res. (In Press).
  • ZIMMERMAN U, MIMIETZ S, ZIMMERMAN H et al.: Hydrogel-based non-autologous cell and tissue therapy. Bio. Techniques (2000) 29 :564–581.
  • •Excellent review showing different options for immunoiso-lation of islets.
  • DE VOS P, DE HAAN B, PATER J, VAN SCHILFGAARDE R: Association between capsule diameter, adequacy of encapsulation and survival of microencapsulated rat islet allografts. Transplantation (1996) 62 (7):893–899.
  • CHICHEPORTICHE D, REACH G: In vitro kinetics of insulin release by microencapsulated rat islets: effect of the size of the microcapsules. Diabetologia (1988) 31:54–57.
  • SCHREZENMEIER J, KIRCHGESSNER J, GERO L, KUNZ LA, BEYER J, MUELLER-KLIESER W: Effect of microencapsu-lation on oxygen distribution in islets organs. Transplantation (1994) 57:1308–1314.
  • DE VOS P, DE HAAN BJ, WOLTERS GHJ, STRUBBE JH, VAN SCHILFGAARDE R: Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia (1997) 40:262–270.
  • VAN SCHILFGAARDE R, DE VOS P: Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. j Mol. Med. (1999) 77:199–205.
  • COLLINS BH, PIRSCH JD, BECKER YT et al.: Long-term results of liver transplantation in patients 60 years of age and older. Transplantation (2000) 70(5):780–783.
  • GOOSEN MFA, O& SHEA GM, GHARAPETIAN HM, CHOU S: Optimization of microencapsulation parameters: semipermeable microcapsules as a bioartificial pancreas. Biotechnol. Bioeng. (1985) 27:146–150.
  • BRANDHORST H, BRANDHORST D, HERING BJ, BRETZEL RG: Significant progress in porcine islet mass isolation utilizing liberase HI for enzymatic low-temperature pancreas digestion. Transplantation (1999) 68 (3):325–326.
  • RAJOTTE RV: Islet cryopreservation protocols. Ann. NY Acad. Sci. (1999) 875:200–207.

Websites

  • http://www.207.239.150.13/tpd TRANSPLANT PATIENT DATASOURCE: (16 February 2000). Richmond, VA, USA: United Network for Organ Sharing. Retrieved 24 September 2000.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.